Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Quantum Biopharma ( (TSE:QNTM) ) just unveiled an update.
Quantum BioPharma Ltd., a company listed on NASDAQ, CSE, and FRA, has announced the closing of a third tranche of its offering, issuing 1,480 Debenture Units for $1,480,000. The company has amended the terms of these units due to a decrease in the market price of its Class B shares, adjusting the conversion price, increasing warrants per unit, and securing obligations against company property. Proceeds from this transaction will support the development of the company’s business model and general working capital.
More about Quantum Biopharma
YTD Price Performance: -16.18%
Average Trading Volume: 132,382
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $6.51M
See more data about QNTM stock on TipRanks’ Stock Analysis page.
